PDSB - PDS Biotechnology Corp

QQQ $ 453.34 $ -0.03 (-0.01 %)

DIA $ 400.17 $ 0.53 (0.13 %)

SPY $ 530.20 $ 0.27 (0.05 %)

TLT $ 92.12 $ -0.28 (-0.3 %)

GLD $ 220.37 $ 0.36 (0.16 %)

Previous Close

$ 3.5

Open

$ 3.45

Bid

$ 3.46 x 200

Ask

$ 3.49 x 100

Day's Range

$ 3.18 - $ 3.55

52 Week Range

$ 2.59 - $ 10.27

Volume

585,393

Average Volume

Market Cap

121.86M

Beta (5Y Monthly)

$ 1.62

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-15-2024	03-31-2024	10-Q
2	03-28-2024	12-31-2023	10-K
3	11-14-2023	09-30-2023	10-Q
4	08-14-2023	06-30-2023	10-Q
5	05-15-2023	03-31-2023	10-Q
6	03-28-2023	12-31-2022	10-K
7	11-14-2022	09-30-2022	10-Q
8	08-08-2022	06-30-2022	10-Q
9	05-11-2022	03-31-2022	10-Q
10	03-31-2022	12-31-2021	10-K
11	11-10-2021	09-30-2021	10-Q
12	08-12-2021	06-30-2021	10-Q
13	05-13-2021	03-31-2021	10-Q
14	03-18-2021	12-31-2020	10-K
15	11-13-2020	09-30-2020	10-Q
16	08-13-2020	06-30-2020	10-Q
17	05-13-2020	03-31-2020	10-Q
18	03-27-2020	12-31-2019	10-K
19	11-07-2019	09-30-2019	10-Q
20	08-01-2019	06-30-2019	10-Q
21	05-14-2019	03-31-2019	10-Q
22	02-21-2019	12-31-2018	10-K
23	11-01-2018	09-30-2018	10-Q
24	08-01-2018	06-30-2018	10-Q
25	05-01-2018	03-31-2018	10-Q
26	03-01-2018	12-31-2017	10-K
27	11-01-2017	09-30-2017	10-Q
28	08-01-2017	06-30-2017	10-Q
29	05-03-2017	03-31-2017	10-Q
30	03-02-2017	12-31-2016	10-K
31	11-01-2016	09-30-2016	10-Q
32	08-03-2016	06-30-2016	10-Q
33	05-03-2016	03-31-2016	10-Q
34	03-08-2016	12-31-2015	10-K
35	11-06-2015	09-30-2015	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

'PDS Biotech's Survival Benefit Is Absurdl...
05/16/2024 15:03:40

https://www.statnews.com/2024/05/16/pds-biotech-survival-benefit/ This is the online edition of Adam's Biotech Scorecard, a...

HC Wainwright & Co. Reiterates Buy on PDS ...
05/15/2024 14:24:17

HC Wainwright & Co. analyst Joseph Pantginis reiterates PDS Biotechnology (NASDAQ:PDSB) with a Buy and maintains $21 pri...

PDS Biotechnology Q1 2024 GAAP EPS $(0.30)...
05/15/2024 12:04:37

PDS Biotechnology (NASDAQ:PDSB) reported quarterly losses of $(0.30) per share which beat the analyst consensus estimate of $(0...

PDS Biotech's VERSATILE-002 Phase 2 Clinic...
05/09/2024 22:09:29

HC Wainwright & Co. Reiterates Buy on PDS ...
05/09/2024 19:35:07

HC Wainwright & Co. analyst Joseph Pantginis reiterates PDS Biotechnology (NASDAQ:PDSB) with a Buy and maintains $21 pri...

Cantor Fitzgerald Reiterates Overweight on...
05/09/2024 15:12:14

Cantor Fitzgerald analyst Louise Chen reiterates PDS Biotechnology (NASDAQ:PDSB) with a Overweight.

PDS Biotech Appoints Stephan Toutain As Ch...
05/02/2024 12:06:32

PDS Biotech To Event To Discuss Positive,...
04/23/2024 12:01:45

Company to Host Key Opinion Leader Event on May 8 at 1:30pm ET to Discuss Updated Results of VERSATILE-002, Unmet Treatment Nee...

B. Riley Securities Reiterates Buy on PDS ...
03/28/2024 16:00:13

B. Riley Securities analyst Kalpit Patel reiterates PDS Biotechnology (NASDAQ:PDSB) with a Buy and lowers the price target f...

12-health-care-stocks-moving-in-wednesdays-intraday-session

12 Health Care Stocks Moving In Wednesday'...
03/27/2024 16:31:07

HC Wainwright & Co. Maintains Buy on PDS B...
03/27/2024 14:28:41

HC Wainwright & Co. analyst Joseph Pantginis maintains PDS Biotechnology (NASDAQ:PDSB) with a Buy and maintains $21 pric...

12-health-care-stocks-moving-in-wednesdays-pre-market-session

12 Health Care Stocks Moving In Wednesday'...
03/27/2024 13:05:57

PDS Biotechnology Q4 EPS $(0.35) Beats $(0...
03/27/2024 11:38:09

PDS Biotechnology (NASDAQ:PDSB) reported quarterly losses of $(0.35) per share which beat the analyst consensus estimate of $(0...

Earnings Scheduled For March 27, 2024
03/27/2024 09:02:44

Companies Reporting Before The Bell • Local Bounti (NYSE:LOCL) is projected to report quarterly loss at $2.41 per share on rev...

Earnings Preview For PDS Biotechnology
03/26/2024 16:01:42

PDS Biotech Announces Publication Of Precl...
03/13/2024 12:04:32

Preclinical research published in Vaccines demonstrates Infectimune® significantly improved quantity and quality of potent mult...

PDS Biotech Appoints Lars Boesgaard As Chi...
11/28/2023 12:32:55

Analyst Expectations for PDS Biotechnology...
11/15/2023 19:01:01

Oppenheimer Maintains Outperform on PDS Bi...
11/15/2023 18:20:21

Oppenheimer analyst Leland Gershell maintains PDS Biotechnology (NASDAQ:PDSB) with a Outperform and lowers the price target ...

Earnings Scheduled For November 14, 2023
11/14/2023 13:23:43

Companies Reporting Before The Bell • CureVac (NASDAQ:CVAC) is likely to report quarterly loss at $0.24 per share on revenue o...